Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of cefazolin prophylaxis relative to cord clamping in elective cesarean delivery and neonatal gut microbiome
NL-OMON47498Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2019
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefazolin in surgical site infection (SSI), endometritis and urinary tract infection (UTI) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Neonatal gut microbiome composition and Neonatal gut microbiome functionality. Started Mar 2019; status: active, not recruiting.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)endometritisurinary tract infection (UTI)
Beyond the preview
Go deeper on NL-OMON47498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47498.